Evidence map›Paper›PMID 36639528›Full record

ArticleBritish journal of cancer2023

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.

D Gareth Evans, Kelly-Anne Phillips, Roger L Milne, Robert Fruscio, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Zerin Hyder, Claire Forde and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

D Gareth EvansGenomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Kelly-Anne PhillipsSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.ORCID http://orcid.org/0000-0002-0475-1771
Roger L MilneCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Robert FruscioDepartment of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
Cezary CybulskiDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Jacek GronwaldDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Jan LubinskiDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Tomasz HuzarskiDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Zerin HyderGenomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Claire FordeGenomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Kelly MetcalfeWomen's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Leigha SenterDivision of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
Jeffrey WeitzelDivision of Clinical Cancer Genomics, Department of Population Sciences, City of Hope, Duarte, CA, USA.
Nadine TungBeth Israel Deaconess Medical Center, Boston, MA, USA.
Dana ZakalikNancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA.
Maria EkholmManchester Academic Health Science Centre, Department of Medical Oncology, The Christie, Manchester, UK.
Ping SunWomen's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Steven A NarodWomen's College Research Institute, Women's College Hospital, Toronto, ON, Canada. steven.narod@wchospital.ca.ORCID http://orcid.org/0000-0001-5798-0626
kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36639528
PMCPMC9938238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.